Caricamento...

Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality and health care expenditure throughout the world. COPD guidelines recommend the use of long-acting muscarinic antagonist (LAMA) either alone or in combination with a long-acting β(2) agonist (LABA). For over 10 y...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Adv Chronic Dis
Autori principali: Babu, Kesavan Suresh, Morjaria, Jaymin Bhagwanji
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406010/
https://ncbi.nlm.nih.gov/pubmed/28491268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622317700822
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !